Myo-inositol oxygenese activity in second trimester of pregnancy: altered myoinositol catabolism in gestational diabetes mellitus

References

• Arner, R.J., et al., 2001. myo-Inositol oxygenase: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol. Biochemical journal, 360 (2), 313–320.
   PubMedGoogle Scholar
• American Diabetes Association, 2013. Standards of medical care in diabetes—2013. Diabetes care, 36 (Supplement 1), S11–S66.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association, 2014. Diagnosis and classification of diabetes mellitus. Diabetes care, 37 (Supplement 1), S81–S90.
   PubMed Web of Science ®Google Scholar
• Caro, H., et al., 1997. Isolation and partial characterisation of insulin-mimetic inositol phosphoglycans from human liver. Biochemical and molecular medicine, 61 (2), 214–228.
   PubMedGoogle Scholar
• Catalano, P.M., et al., 2003. Gestational diabetes and insulin resistance: role in short-and long-term implications for mother and fetus. The journal of nutrition, 133 (5), 1674S–1683S.
   PubMed Web of Science ®Google Scholar
• Clements, R. and Darnell, B., 1980. Myo-inositol content of common foods: development of a high-myo-inositol diet. The american journal of clinical nutrition, 33 (9), 1954–1967.
   PubMed Web of Science ®Google Scholar
• Coniff, R.F., et al., 1995. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM: a placebo-controlled dose-comparison study. Diabetes care, 18 (6), 817–824.
   PubMed Web of Science ®Google Scholar
• Costantino, D., et al., 2009. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. European review for medical and pharmacological sciences, 13 (2), 105–110.
   PubMed Web of Science ®Google Scholar
• Croze, M.L. and Soulage, C.O., 2013. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie, 95 (10), 1811–1827.
   PubMed Web of Science ®Google Scholar
• D’Anna, R., et al., 2012. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecological endocrinology, 28 (6), 440–442.
   PubMed Web of Science ®Google Scholar
• Dyck, P.J., Minnerath, S.R., and O'Brien, P.C., 1989. Nerve glucose, sorbitol, fructose, and myo-inositol at various time after feeding in streptozotocin-induced diabetes in rats. Mayo clinic proceedings, 64 (8), 905–910.
   PubMed Web of Science ®Google Scholar
• Farren, M., et al., 2017. The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial. Diabetes care, 40 (6), 759–763.
   PubMed Web of Science ®Google Scholar
• Gayoso-Diz, P., et al., 2013. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC endocrine disorders, 13 (1), 47.
   PubMedGoogle Scholar
• Ikezaki, H., et al., 2014. The utility of urinary myo-inositol as a marker of glucose intolerance. Diabetes research and clinical practice, 103 (1), 88–96.
   PubMed Web of Science ®Google Scholar
• Kunjara, S., et al., 2000. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Molecular genetics and metabolism, 69 (2), 144–158.
   PubMed Web of Science ®Google Scholar
• Matthews, D., et al., 1985. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28 (7), 412–419.
   PubMed Web of Science ®Google Scholar
• Mertoglu, C., et al., 2018. Does myo-inositol oxygenase, the only enzyme to catalyze myo-inositol in vivo, play a role in the etiology of polycystic ovarian syndrome? Gynecological endocrinology, 34 (5), 418–421.
   PubMed Web of Science ®Google Scholar
• Metzger, B.E., Coustan, D.R., and Committee, O., 1998. Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes care, 21, B161.
   PubMed Web of Science ®Google Scholar
• Murphy, A., et al., 2016. Urinary excretion of myo-inositol and D-chiro-inositol in early pregnancy is enhanced in gravidas with gestational diabetes mellitus. Reproductive sciences, 23 (3), 365–371.
   PubMed Web of Science ®Google Scholar
• Scioscia, M., et al., 2007. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. Gynecologic and obstetric investigation, 64 (4), 217–223.
   PubMed Web of Science ®Google Scholar
• Tominaga, T., et al., 2016. Transcriptional and translational modulation of myo-inositol oxygenase (miox) by fatty acids: implications in renal tubular injury induced in obesity and diabetes. The journal of biological chemistry, 291 (3), 1348–1367.
   PubMed Web of Science ®Google Scholar
• Whiting, P.H., Palmano, K., and Hawthorne, J.N., 1979. Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin-induced diabetes. Biochemical journal, 179 (3), 549–553.
   PubMed Web of Science ®Google Scholar
• World Health Organization, 2006. Diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF Consultation. Geneva: World Health Organization, 1–46.
   Google Scholar
• Yang, B., et al., 2010. High glucose-induced DNA-binding activities of nuclear factor of activated T cells 5 and carbohydrate response element binding protein to the myo-inositol oxygenase gene are inhibited by sorbinil in peripheral blood mononuclear cells from patients with type 1 diabetes mellitus and nephropathy. International journal of diabetes mellitus, 2 (3), 169–174.
   Google Scholar